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The innovation of composite vascularized allotransplantation has provided plastic and reconstructive
surgeons with the ultimate tool for those patients that present with facial deformities that cannot be
reconstructed with classical or more traditional techniques. Transplanting normal tissues allows for a
true restorative surgery. Initial experiences included the substitution of missing anatomy, whereas
after the ﬁrst world’s full-face transplant performed in Barcelona in March 2010, a true ablative sur-
gery with a total restoration proved to be effective. We review the world’s experience and the per-
formance of our restorative protocol to depict this change in the reconstructive paradigm of facial
transplantation. Facial transplants should be performed after a careful analysis of the defect, with a
comprehensive ablation plan following esthetic units with sacriﬁce of all required tissues with a focus
of global restoration of anatomy, aesthetics and function, respecting normal functioning muscles.
Nowadays, facial transplants following strict esthetic units should restore disﬁgurement extending to
small central areas, whereas major defects may require a total ablation and restoration with full-face
transplants.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Face transplantation became a reality in November 2005,
following the initial experience of the Amiens Team.1 It broke
boundaries and started a new frontier for reconstructive surgery
and transplantation medicine. This was indeed the birth of restor-
ative surgery in contrast to reconstructive surgery.
Few teams followed them in the exploration of this new path
for the reconstruction of severe facial deformity.2e7 These pio-
neering experiences proved the safety, efﬁcacy and reproducibility
of facial transplant outcomes. They also showed that a robust
protocol and team approach warrant safe and excellent results in
this complex experimental surgery. From 2005 to 2010, different
amounts of facial tissues were transplanted in 11 facial trans-
plantations, but a full-face transplant was still theoretical. The
indication varied, but all facial transplants had in common the
limitation of the resection to the area involved in the deformity
and small amount of normal skin and soft tissues surrounding
these destroyed tissues.ciates Ltd. Published by Elsevier LtIn 2010 we performed the world’s ﬁrst full-face trans-
plantation,5,8e10 which included all facial soft tissue structures,
intraoral structures, and facial skeleton. This consisted in a type VB
face transplant according to Lengele’s classiﬁcation.11 The indica-
tion surpassed that of previous face transplants. Many facial units
were involved, thus a reconstructive approach was implemented
according to the facial unit criteria.12 Herein we describe the
reconstructive plan approach used to this unique facial transplant,
and we analyze the change in the reconstructive paradigm in the
following 14 facial transplants thereafter.2. Material and methods
All facial transplants performed between November 2005 and
July 2013 were analyzed. The information was retrieved from
published literature; press releases, congress proceedings and
direct information form the head surgeon of the transplant teams.
Facial transplants were studied concerning the amount of facial
units transplanted, normal tissues sacriﬁced, and type of transplant.
The transplants were also divided in two groups of patients:
facial transplants performed before march 2010 and after march
2010 (date of the ﬁrst full-face transplantation) and compared in
regards of the type of indication and tissues ablated.d. All rights reserved.
Table 1
Global list of facial transplants to date.
Number Team Date Etiology Type
1 Amiens Nov 05 Dog bite Partial
2 China Apr 06 Bear bite Partial þ Bone
3 Paris Jan 07 Neuroﬁbromatosis Partial
4 Cleveland Dec 08 Gunshot Partial þ Bone
5 Paris Mar 09 Gunshot Partial þ Bone
6 Paris Apr 09 Burn Partial þ Hands
7 Boston Apr 09 Burn Partial þ Bone
8 Valencia Aug 09 Postoncological Partial þ Bone þ Tongue
9 Paris Sep 09 Gunshot Partial
10 Amiens 2009 Burn Partial þ Bone
11 Seville Jan 10 Neuroﬁbromatosis Partial þ Bone
12 Barcelona Mar 10 Gunshot Full þ Bone
13 Paris Jun 10 Neuroﬁbromatosis Full
14 Paris 2010 Gunshot Partial þ Bone
15 Paris 2010 Neuroﬁbromatosis Partial
16 Boston Mar 2011 Burn Full
17 Boston Apr 2011 Burn Full
18 Boston May 2011 Chimp Attack Full þ Hands
19 Gent Dec 2011 Gunshot Partial þ Bone
20 Antalya Jan 2012 Burn Full
21 Ankara Feb 2012 Burn Full
22 Ankara Mar 2012 Gunshot Partial þ Bone
23 Baltimore Apr 2012 Gunshot Full þ Bone þ Tongue
24 Amiens Jun 2012 Arterio-venous
malformation
Partial
25 Boston Feb 2013 Burn Full
26 Gliwice May 2013 Trauma Near-Total þ Bone
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REVIEW2.1. The Barcelona restorative protocol
Patients considered for facial transplantation are evaluated in a
reconstructive facial clinic. The deformity is analyzed by clinical
inspection, rehabilitation services and X-ray examination including
Angio-CT-Scan andMRI and all reconstructive plans are considered.
Patients with an indication for facial transplantation are included in
the transplant team program and a complete medical, psycholog-
ical, and analytical work-up is carried out which ﬁnalizes with the
submission on a case-by-case basis to the Ethics Committee. The
patient is then submitted to the regional and national transplant
bodies for ﬁnal administrative approval. During thewholework-up,
an individual reconstructive plan, which includes areas to be
extirpated, expected defect, and desired functional/anatomical
outcome, is delineated.
3. Results
3.1. Analysis of global results
A total of 26 facial transplants have been performed in the world
in 8 years.2e6,13e22 The etiology of the deformity includes 8 gunshot
injuries, 8 burn deformities, 4 neuroﬁbromatosis, 1 high ﬂow
arterio-venous malformation, 1 postoncological deformity, 1 dog
bite, 1 bear bite, 1 chimp attack, 1 traumatic injury. Out of 26 facial
transplantations, 17 facial transplants are partial (66%), and 9 are
full-face transplants (Table 1).
Before face transplant number 12 (the ﬁrst full-face trans-
plant) all transplant were partial and included different amounts
of soft tissues and bone. Among them, 6 followed esthetic units
with few or no normal tissue excised during the transplantation,
and 5 did not followed any esthetic unit and resolved the
deformity by replacing the missing anatomy by transplanted
parts.
After the ﬁrst full-face transplant, a change in the reconstructive
paradigm occurred. The classical concepts of esthetic facial recon-
struction were applied to facial transplantation. Out of the next 14facial transplants, 8 were full-face transplants (with extirpation of
deformed and normal tissues to achieve a complete functional and
esthetic restoration), and 6 were partial transplants that followed
strict esthetic units.
3.2. Analysis of Barcelona experience
The deformity of Patient 1 in the Barcelona facial transplant
protocol included the central portion of the face, absence of the
nose, subtotal destruction of the lips, scarred tissue on eyelids,
cheeks, neck and forehead. The bony skeleton had destruction of
maxilla and zygomatic bones, nasal bones, and partial destruction
of mandible. There were areas of normal tissue, which included
parts of the forehead and eyebrows, parts of the eyelids and cheeks.
Fig. 1a shows disﬁgured and non-disﬁgured areas. A complete
analysis of the deformity was undertaken (Fig. 1b and c), coupled
with functional deﬁcits and expected outcomes. The concepts of
ablative surgery and functional reconstruction were applied, and a
total resection of the face and destroyed facial bones and restora-
tion of the missing anatomy with a full-face transplant with facial
bones, intraoral structures and teeth was undertaken (Fig. 1d). The
former was considered the best treatment plan to restore function
and aesthetics and to reintegrate him into society. Total follow up is
42 months.
4. Discussion
Remarkable advances in research, technology, and clinical
experience inmedicine over the past few decades have resulted in a
strong surge of development in reconstructive surgery. The inno-
vation of composite vascularized allotransplantation has provided
plastic and reconstructive surgeons with the ultimate tool for those
patients that present with deformities that cannot be reconstructed
with classical or more traditional techniques. However, few ques-
tion arise when considering composite allotransplantation in the
reconstructive ladder23:
- Is it ever indicated and, if so, how should it be accomplished?
- Is it a question of plain restorative surgery of missing parts?, or
- a true reconstructive master plan that includes a complex
ablative surgery coupled with a natureefashion composite Allo-
microvascular ﬂap?
- Given the risks and side effects of mandatory immunosup-
pression, will the expected outcomes and improvement in
quality of life be worth enough to sustain the risks?
Thus, a decision making process has to be implemented in any
facial transplantation protocol.
When we started our program in 2007, we introduced the
philosophy of reconstructive surgery into the facial trans-
plantation model. It was no longer a program of exchanging
missing anatomy parts but creating a new face for a human being.
Proper reconstructive and restorative surgery has to start with
the analysis of the deformity, delineation of the extension of the
ablative surgery extending to all esthetic units involved (with the
sacriﬁce of normal tissues if necessary), and the reconstruction of
the deformity with a facial transplantation. However, a word of
caution is also mandatory when considering the resection of the
periorbital structures. Replacing the eyelids is a new revolution in
the reconstruction of this complex structure. There are not
available reconstructive options to restore eyelid function with
classical techniques. Should the transplant fail or function is
inappropriate, vision would be at risk. Therefore, it should be
advocated to preserve as much as normal structures as possible
(conjunctiva, muscles, etc) to protect the eyes in these
Fig. 1. a: Preoperative picture of patient depicting facial disﬁgurement. b: Planned reconstructive ablating surgery. Area in White covering all scarred and disﬁgured soft tissues.
Area in shadow areas planned to be resected en block as a complete facial unit. c: Planned area of facial skeleton to be ablated and reconstructed. d and e: Postoperative view of
patient following full-face transplant type VB 8 (full face þ facial skeleton). Area in shadow shows area transplanted in comparison to preoperative plan.
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restoration with face transplants, preservation all viable native
muscles is also advocated.
As it has been mentioned and published before, this approach
proved to be effective, safe, and robust. It provided to our patient
with an excellent outcome, and many other teams throughout the
world have followed it. Indeed, the initial criticism to the sacriﬁce
of normal tissue that involved full-face transplantation in trauma
cases, shifted to an evolution of facial transplantation. Total abla-
tion of tissues following strict facial units and restoration of the
missing anatomy with a face transplant should render the best
anatomic and functional outcome. Moreover, the new normal
anatomy should allow for normal secondary procedures to be un-
dertaken as in any other patient.24 The former should trigger a new
paradigm in reconstruction. Severe deformities may be restored
with facial transplantation, allowing patients to recover a new life,
and offering surgeons a new tool to obtain new normal tissues, new
faces to work onto. It is a new technique added to the reconstruc-
tive ladder that allows for total ablation and restoration. It has to be
remembered, though, that many times we wish to be at the up-
permost rung of the ladder, namely complex microsurgery or
composite vascularized transplantation, since outcome is more
than ever deﬁned in terms of a complex of function and appear-
ance, rather than achievement of closure.25 Considering graft fail-
ure (either acute or chronic) this approach would allow traditional
reconstructive surgery to ﬁll the defect; however, this would be an
intervention to close the defect and provide as much function as
possible, with limited outcomes. The best situation would be a
return to the pre-transplant condition. Given the nature of the
resulting defect after graft explantation and available reconstruc-
tive techniques, patients must be informed that in many situations
a new transplantation may be necessary in case the allograft is
removed. In our patient, graft failure would compromise life.
Reconstructionwith large microvascular ﬂaps would merely ﬁll thedefect and protect the eyes. A new facial transplantation would be
necessary, similarly to other face transplants recipients.
Similarly to other disciplines of transplant medicine, long-term
outcomes and graft survival depend on mandatory immunosup-
pression for life. The aim is to achieve a rejection free status with
the minimum requirements of drugs minimizing side effects and
adverse events. Still, immunosuppression therapy is not risk free.
Aside from the increased risk for infections, each agent can produce
different adverse effects, which may be strengthened by other
concomitant medications. Mild to moderate side effects include
negative effects on the central and peripheral nervous system
(tremor, headache, insomnia, paresthesias, uncoordinated move-
ments, confusion, convulsions, vertigo); adverse metabolic effects
(glucose intolerance, hyperkalemia, hypomagnesemia); gastroin-
testinal effects; and leucopoenia, thrombocytopenia and anemia.
Dose adjustments in these mild and moderate side effects must be
evaluated on a case-by-case basis assessing the risks of serious side
or toxic effects and acute rejection development. A team approach
must be implemented in the postoperative period and during the
chronic phase. Patients must be reviewed not only for the assess-
ment of rejection of the transplanted graft and the development of
opportunistic infections, but also in regards of the maintenance of
homeostasis and proper function of organs and systems. Apart from
the ordinary analytical work-up during each postoperative control
and clinic visit, a good anamnesis of all organs and systems should
proceed. Understanding risks and beneﬁts of face transplantation is
essential to obtain good long-term outcomes. Physicians and pa-
tientsmust understand both in order to determine good indications
for facial transplantation, informed consent, and excellent post-
operative quality of life.
Ethical approval
Facial Transplantation program has been approved by the Clin-
ical ethics Committee of the University Hospial Vall d’hebron and
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REVIEWthe Catalan Organ Transplantation Body (OCATT) and the National
Organ Organization (ONT).
The patient record also passed an individual accreditation by
these bodies following the steps required by the Sapanish Law for
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